Anatomy of stock market scams TheStar Sat, Oct 03, 2020 09:40am
"Thirdly, one must look out for companies raising money through share placements, especially if the proceeds are to be used as working capital or to repay loans. The smaller the amount raised through a placement, the higher the scrutiny it warrants.
Also, if the bulk is used to repay loans, there is also a possibility of the company taking up more loans again. So, why risk taking up a stake in such companies?
Bintai raised money through Private Placement to partially pay it's debts of RM160 million.
FOR IMMEDIATE RELEASE BINTAI KINDEN’S UNIT APPOINTED EXCLUSIVE DISTRIBUTOR OF COLD CHAIN BOX FOR STORING COVID-19 VACCINE Kuala Lumpur, 8 January 2021 – Bintai Kinden Corporation Berhad’s (“Bintai Kinden” or the “Company”, Bursa: BINTAI (6998), Bloomberg: BKC:MK, Reuters: BKCB.KL)(民 泰近電有限公司) subsidiary Bintai Healthcare Sdn Bhd (“Bintai Healthcare”) has been appointed as the exclusive distributor for Greenie Medi Cold Chain Box designed for the storage and distribution of Covid-19 vaccine in Malaysia. Bintai Healthcare has also been appointed as an authorised distributor for the product in South East Asia countries. To formalise the deal, Bintai Healthcare had today signed a distribution agreement with SLAB Asia Co., Ltd. (“SLAB Asia”) to distribute the full range of Greenie Medi Cold Chain Box products in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam. Greenie Medi Cold Chain Box was designed for the exclusive use in transporting and storing medical products at very low temperatures. It keeps the inbox temperature at negative 70 degrees Celsius (-70℃) for up to 120 hours. SLAB Asia is one of the leading cold chain equipment manufacturers in South Korea and operates Korea’s only ISTA 7D/7E certified private test lab which offers its customers international recognized quality assurance. ISTA 7D/7E is a test standard set by Center for Drug Evaluation and Research under the United States Food and Drug Administration in certifying compatibility and adequacy for transporting medical grade products. The product, which is tested to meet ISTA 7D/7E requirements, is designed specifically to enable proper storage and distribution of vaccines, including the highly anticipated COVID-19 vaccine. Mr. Ong Choon Lui (王春雷), Managing Director of Bintai Kinden said, the Company understands the importance of supply chain stability especially related to vaccine shipments. “As a socially responsible organisation, we are here to support the Government’s initiatives in vaccine distribution and to complement the existing cold chain infrastructure and provide comprehensive solutions to meet critical needs in times like these and to support the needs for COVID-19 vaccine distribution. “Greenie Medi Cold Chain Box are the ideal solutions for getting temperature sensitive drugs, biologics and vaccines safely to the end users across Malaysia and beyond,” he added. The agreement is not expected to have any material effect on the issued and paid up share capital of Bintai Kinden but is expected to contribute positively towards the future earnings of the Group. Bintai Kinden had in October 2020 ventured into distribution of Covid-19 vaccine. Bintai Healthcare was granted the exclusive rights from Generex Biotechnology Corporation and its subsidiary NuGenerex Immuno-Oncology Inc. to distribute, sell and commercialize the Covid-19 vaccine in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, Philippines, Singapore, Thailand and Vietnam. It has also been given the first right of refusal to distribute and market the vaccine within Australia, New Zealand and the global halal market. About Bintai Kinden Corporation Berhad Bintai Kinden Corporation Berhad specializes in mechanical and electrical engineering services which include electrical, mechanical and power supply installation, instrumentation and building automation, and maintenance of electrical and mechanical systems. The Company also constructs power plants and transmission lines, and develops and invests in properties. -EndIssued on behalf of Bintai Kinden Corporation Berhad Media and Investors Contact: Michelle Kuan Public Relations Consultancy
KUALA LUMPUR: Bintai Kinden Corporation Bhd (BKC) has been appointed as the exclusive distributor for Greenie Medi Cold Chain Box designed for the storage and distribution of Covid-19 vaccine in Malaysia.
BKC subsidiary Bintai Healthcare Sdn Bhd (BHSB) had entered into a distribution agreement with SLAB Asia Co Ltd to distribute the full range of Greenie Medi Cold Chain Box products in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam.
The Greenie Medi Cold Chain Box designed for the exclusive use in transporting and storing medical products at very low temperatures. It keeps the inbox temperature at negative 70 degrees Celsius (-70 celsius) for up to 120 hours.
SLAB Asia is one of the leading cold chain equipment manufacturers in South Korea and operates Korea's only ISTA 7D/7E certified private test lab which offers its customers internationally recognized quality assurance.
Similar News Duterte urged to appoint Covid-19 vaccine czar Malaysia aims to become vaccine-manufacturing country [NSTTV] Russia: 20 countries have ordered new 'Sputnik' vaccine Bahrain becomes second country to approve Pfizer-BioNTech vaccine ISTA 7D/7E is a test standard set by the Center for Drug Evaluation and Research under the United States Food and Drug Administration in certifying compatibility and adequacy for transporting medical-grade products.
The product, which is tested to meet ISTA 7D/7E requirements, is designed specifically to enable proper storage and distribution of vaccines, including the highly anticipated Covid-19 vaccine.
BKC managing director Ong Choon Lui said the company understands the importance of supply chain stability especially related to vaccine shipments.
Ong said as a socially responsible organisation, the company is here to support the government's initiatives in vaccine distribution and to complement the existing cold chain infrastructure.
"Greenie Medi Cold Chain Box are the ideal solutions for getting temperature-sensitive drugs, biologics and vaccines safely to the end users across Malaysia and beyond," he said.
The agreement is not expected to have any material effect on the issued and paid-up share capital of BKC but is expected to contribute positively towards the future earnings of the group.
BKC had in October 2020 ventured into distribution of Covid-19 vaccine.
BHSB was granted the exclusive rights from Generex Biotechnology Corporation and its subsidiary NuGenerex Immuno-Oncology Inc to distribute, sell and commercialize the Covid-19 vaccine in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, Philippines, Singapore, Thailand and Vietnam.
It has also been given the first right of refusal to distribute and market the vaccine within Australia, New Zealand and the global halal market.
The pengoreng not yet take control ma as on 6/1/21 there are 31,800,000 new listing at 0.645. Give pengoreng 2-3 weeks time or longer 2 months to take control first. Then RM3 is not a dream.
Latest....We have completed our ex vivo human trial of Corvid19 patient samples n can confirm that the results of the T cell activation n antibody screen have enable to select li key Sars cov 2 epitopes for our vaccine formulation.I will provide an update on these results as well as these results of our ongoing immunogenicity study that will confirm the commercial viability of our Li key vax."
Now the Chinese also agreee to set up a joint research team and a joint entity in China that shall jointly develop n industralize the GNBT internationally patented li Key innovative technology for a Sars cov 2 coronavirus peptide vax.
Pfizer vaccine coming by next month for about 1m frontliners. The Cold Storage Box is needed and Bintai is the exclusive distributor for Greenie Medi Cold Chain Box for 10 countries.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
BennyWhittman
1,215 posts
Posted by BennyWhittman > 2021-01-08 14:52 |
Post removed.Why?